Search Results - "TERABE, Masaki"

Refine Results
  1. 1
  2. 2

    Tissue-Specific Roles of NKT Cells in Tumor Immunity by Terabe, Masaki, Berzofsky, Jay A

    Published in Frontiers in immunology (15-08-2018)
    “…NKT cells are an unusual population of T cells recognizing lipids presented by CD1d, a non-classical class-I-like molecule, rather than peptides presented by…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The immunoregulatory role of type I and type II NKT cells in cancer and other diseases by Terabe, Masaki, Berzofsky, Jay A.

    Published in Cancer Immunology, Immunotherapy (01-03-2014)
    “…NKT cells are CD1d-restricted T cells that recognize lipid antigens. They also have been shown to play critical roles in the regulation of immune responses. In…”
    Get full text
    Journal Article
  5. 5

    Altered Lipid Tumor Environment and Its Potential Effects on NKT Cell Function in Tumor Immunity by Tiwary, Shweta, Berzofsky, Jay A, Terabe, Masaki

    Published in Frontiers in immunology (18-09-2019)
    “…Natural killer T (NKT) cells are CD1d restricted T cells that mostly recognize lipid antigens. These cells share characteristics with both adaptive and innate…”
    Get full text
    Journal Article
  6. 6

    Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma by Frederico, Stephen C, Hancock, John C, Brettschneider, Emily E S, Ratnam, Nivedita M, Gilbert, Mark R, Terabe, Masaki

    Published in Frontiers in oncology (10-05-2021)
    “…The use of immunotherapies for the treatment of brain tumors is a topic that has garnered considerable excitement in recent years. Discoveries such as the…”
    Get full text
    Journal Article
  7. 7

    Chapter 8 The Role of NKT Cells in Tumor Immunity by Terabe, Masaki, Berzofsky, Jay A.

    Published in Advances in Cancer Research (2008)
    “…NKT cells are a relatively newly recognized member of the immune community, with profound effects on the rest of the immune system despite their small numbers…”
    Get full text
    Book Chapter
  8. 8

    NKT Cells in Tumor Immunity: Opposing Subsets Define a New Immunoregulatory Axis by Berzofsky, Jay A, Terabe, Masaki

    Published in The Journal of immunology (1950) (15-03-2008)
    “…NKT cells are true Ag-specific T cells that also have innate properties and form a bridge between the innate and adaptive immune systems. Distinct NKT cell…”
    Get full text
    Journal Article
  9. 9

    NKT cell networks in the regulation of tumor immunity by Robertson, Faith C, Berzofsky, Jay A, Terabe, Masaki

    Published in Frontiers in immunology (28-10-2014)
    “…CD1d-restricted natural killer T (NKT) cells lie at the interface between the innate and adaptive immune systems and are important mediators of immune…”
    Get full text
    Journal Article
  10. 10

    Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients by Castiello, Luciano, Sabatino, Marianna, Ren, Jiaqiang, Terabe, Masaki, Khuu, Hanh, Wood, Lauren V, Berzofsky, Jay A, Stroncek, David F

    Published in Clinical cancer research (01-07-2017)
    “…Despite the vast number of clinical trials conducted so far, dendritic cell (DC)-based cancer vaccines have mostly shown unsatisfactory results. Factors and…”
    Get full text
    Journal Article
  11. 11

    The contrasting roles of NKT cells in tumor immunity by Berzofsky, Jay A, Terabe, Masaki

    Published in Current molecular medicine (01-08-2009)
    “…NKT cells are true T cells that serve as a bridge between the innate and adaptive immune system, acting as first responders. They recognize lipid antigens…”
    Get more information
    Journal Article
  12. 12

    Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy by Terabe, Masaki, Robertson, Faith C., Clark, Katharine, De Ravin, Emma, Bloom, Anja, Venzon, David J., Kato, Shingo, Mirza, Amer, Berzofsky, Jay A.

    Published in Oncoimmunology (04-05-2017)
    “…Checkpoint inhibition has established immunotherapy as a major modality of cancer treatment. However, the success of cancer immunotherapy is still limited as…”
    Get full text
    Journal Article
  13. 13

    Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity by Kato, Shingo, Berzofsky, Jay A, Terabe, Masaki

    Published in Frontiers in immunology (22-02-2018)
    “…Natural killer T (NKT) cells are a unique T cell subset that exhibits characteristics from both the innate immune cells and T cells. There are at least two…”
    Get full text
    Journal Article
  14. 14

    The Role of NKT Cells in Glioblastoma by Brettschneider, Emily E. S., Terabe, Masaki

    Published in Cells (Basel, Switzerland) (30-06-2021)
    “…Glioblastoma is an aggressive and deadly cancer, but to date, immunotherapies have failed to make significant strides in improving prognoses for glioblastoma…”
    Get full text
    Journal Article
  15. 15

    Cross-Regulation between Type I and Type II NKT Cells in Regulating Tumor Immunity: A New Immunoregulatory Axis by Ambrosino, Elena, Terabe, Masaki, Halder, Ramesh C, Peng, Judy, Takaku, Shun, Miyake, Sachiko, Yamamura, Takashi, Kumar, Vipin, Berzofsky, Jay A

    Published in Journal of Immunology (15-10-2007)
    “…Negative immunoregulation is a major barrier to successful cancer immunotherapy. The NKT cell is known to be one such regulator. In this study we explored the…”
    Get full text
    Journal Article
  16. 16

    A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance by Terabe, Masaki, Swann, Jeremy, Ambrosino, Elena, Sinha, Pratima, Takaku, Shun, Hayakawa, Yoshihiro, Godfrey, Dale I., Ostrand-Rosenberg, Suzanne, Smyth, Mark J., Berzofsky, Jay A.

    Published in The Journal of experimental medicine (19-12-2005)
    “…The importance of immunoregulatory T cells has become increasingly apparent. Both CD4+CD25+ T cells and CD1d-restricted NKT cells have been reported to…”
    Get full text
    Journal Article
  17. 17

    Synergistic Enhancement of CD8+ T Cell–Mediated Tumor Vaccine Efficacy by an Anti–Transforming Growth Factor-β Monoclonal Antibody by Terabe, Masaki, Ambrosino, Elena, Takaku, Shun, O'Konek, Jessica J, Venzon, David, Lonning, Scott, McPherson, John M, Berzofsky, Jay A

    Published in Clinical cancer research (01-11-2009)
    “…Purpose: Transforming growth factor-β (TGF-β) is an immunosuppressive cytokine, having direct suppressive activity against conventional CD4 + and CD8 + T cells…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    IL-15 as a mediator of CD4⁺ help for CD8⁺ T cell longevity and avoidance of TRAIL-mediated apoptosis by Oh, SangKon, Perera, Liyanage P, Terabe, Masaki, Ni, Ling, Waldmann, Thomas A, Berzofsky, Jay A

    “…CD4⁺ helper T cells contribute to the induction and maintenance of antigen-specific CD8⁺ T cells. Their absence results in short-lived antigen-specific CD8⁺ T…”
    Get full text
    Journal Article